Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000221363 | SCV000269349 | benign | not specified | 2014-11-24 | criteria provided, single submitter | clinical testing | Ala64Ala in exon 2 of MYOM1: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 11.6% (473/4072) of A frican American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs9964300). |
Ambry Genetics | RCV000221363 | SCV000739805 | likely benign | not specified | 2022-05-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001520127 | SCV001729149 | benign | Hypertrophic cardiomyopathy | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001651074 | SCV001870009 | benign | not provided | 2019-05-06 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001651074 | SCV005248217 | benign | not provided | criteria provided, single submitter | not provided |